BR1100978A - Rpocesso para preparar uma composição que promove a hemostase derivada do plasma ou das frações do plasma, e, composição. - Google Patents

Rpocesso para preparar uma composição que promove a hemostase derivada do plasma ou das frações do plasma, e, composição.

Info

Publication number
BR1100978A
BR1100978A BR1100978-0A BR1100978A BR1100978A BR 1100978 A BR1100978 A BR 1100978A BR 1100978 A BR1100978 A BR 1100978A BR 1100978 A BR1100978 A BR 1100978A
Authority
BR
Brazil
Prior art keywords
composition
plasma
preparing
derived
promotes hemostasis
Prior art date
Application number
BR1100978-0A
Other languages
English (en)
Inventor
Daphne C Tse
Samia S Mankarious
Shu-Len Liu
William R Thomas
Melaine Alpern
Stanley T Enomoto
Cataline M Garanchon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25037952&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100978(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to BR1100978-0A priority Critical patent/BR1100978A/pt
Publication of BR1100978A publication Critical patent/BR1100978A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR1100978-0A 1991-09-05 1997-05-14 Rpocesso para preparar uma composição que promove a hemostase derivada do plasma ou das frações do plasma, e, composição. BR1100978A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1100978-0A BR1100978A (pt) 1991-09-05 1997-05-14 Rpocesso para preparar uma composição que promove a hemostase derivada do plasma ou das frações do plasma, e, composição.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75515691A 1991-09-05 1991-09-05
BR1100978-0A BR1100978A (pt) 1991-09-05 1997-05-14 Rpocesso para preparar uma composição que promove a hemostase derivada do plasma ou das frações do plasma, e, composição.

Publications (1)

Publication Number Publication Date
BR1100978A true BR1100978A (pt) 2000-04-11

Family

ID=25037952

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100978-0A BR1100978A (pt) 1991-09-05 1997-05-14 Rpocesso para preparar uma composição que promove a hemostase derivada do plasma ou das frações do plasma, e, composição.

Country Status (8)

Country Link
EP (1) EP0602173B1 (pt)
JP (2) JP2887329B2 (pt)
AT (1) ATE180492T1 (pt)
AU (1) AU675051B2 (pt)
BR (1) BR1100978A (pt)
CA (1) CA2117058A1 (pt)
DE (1) DE69229272T2 (pt)
WO (1) WO1993005067A1 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208179B1 (en) 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
WO1996003112A1 (en) * 1993-05-04 1996-02-08 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
WO1995025748A1 (en) * 1994-03-18 1995-09-28 Baxter International Inc. Topical fibrinogen complex
DE69512416T3 (de) * 1994-07-14 2011-12-15 Croix Rouge De Belgique Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5658588A (en) * 1995-03-31 1997-08-19 University Of Cincinnati Fibrinogen-coated liposomes
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
EP0869804A4 (en) * 1995-06-07 2001-08-16 American Nat Red Cross SUPPLEMENTED AND NON-SUPPLEMENTED SEALANTS, METHOD FOR THE PRODUCTION AND USE THEREOF
AU715822B2 (en) * 1996-03-15 2000-02-10 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Tissue adhesive suitable for spray application
US6168788B1 (en) 1997-09-26 2001-01-02 Leon Wortham Fibrin glue without fibrinogen and biosealant compositions and methods
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6780411B2 (en) * 1998-05-01 2004-08-24 Zymogenetics, Inc. Tissue sealant compositions
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
JP4680483B2 (ja) 2001-02-23 2011-05-11 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組織および臓器の治療および修復に用いるための幹細胞マトリックスの迅速な調製方法
JP4527901B2 (ja) * 2001-04-27 2010-08-18 シスメックス株式会社 フィブリノゲン測定用標準品および精度管理物質
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
WO2004024195A1 (en) 2002-09-10 2004-03-25 American National Red Cross Hemostatic dressing
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
CN100437279C (zh) * 2005-08-15 2008-11-26 友达光电股份有限公司 有源光罩除尘设备
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
WO2009020612A1 (en) 2007-08-06 2009-02-12 Stb Lifesaving Technologies, Inc. Methods and dressing for sealing internal injuries
EP2567692B1 (en) 2008-02-27 2016-04-06 Biomet Biologics, LLC Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
ES2933951T3 (es) * 2018-01-31 2023-02-15 Rokit Healthcare Inc Composición de tinta biológica para la regeneración de cartílagos, método de fabricación de armazón personalizado para regeneración de cartílagos usando la misma y armazón personalizado para regeneración de cartílagos fabricado con el método de fabricación
EP3934542A1 (en) 2019-03-06 2022-01-12 Gambro Lundia AB Device and method for the delivery of a thrombin activated fibrin sealant
CA3224328A1 (en) 2021-08-13 2023-02-16 Biotest Ag Fibrinogen compositions and methods of preparation
EP4387993A1 (en) 2021-08-18 2024-06-26 Biotest AG Dry heat treatment of plasma-derived factor viii

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5132687B2 (pt) * 1972-06-15 1976-09-14
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
ATE20824T1 (de) * 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
SK294292A3 (en) * 1991-09-27 1994-06-08 Octapharma Ag Tissue adhesive and method of its production
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.

Also Published As

Publication number Publication date
WO1993005067A1 (en) 1993-03-18
DE69229272D1 (de) 1999-07-01
EP0602173B1 (en) 1999-05-26
AU675051B2 (en) 1997-01-23
DE69229272T2 (de) 2000-02-03
AU2577992A (en) 1993-04-05
JP2887329B2 (ja) 1999-04-26
JPH1121249A (ja) 1999-01-26
ATE180492T1 (de) 1999-06-15
CA2117058A1 (en) 1993-03-18
EP0602173A4 (en) 1995-03-01
EP0602173A1 (en) 1994-06-22
JPH07501517A (ja) 1995-02-16

Similar Documents

Publication Publication Date Title
BR1100978A (pt) Rpocesso para preparar uma composição que promove a hemostase derivada do plasma ou das frações do plasma, e, composição.
DE69739996D1 (de) Methoden und Zusammensetzungen zur Herstellung von Polypeptiden
DK0541507T3 (da) Thrombin samt fremgangsmåde til dets fremstilling
HUT77431A (hu) Fonálféregből kivont szerinproteáz-inhibitorok és véralvadásgátló proteinek
DE69002395D1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
ES2125530T3 (es) Secuencia de acidos nucleicos que codifica una enzima semejante a tripsina y procedimiento para producir la enzima.
ES535409A0 (es) Procedimiento para pasterizar un plasma de radical-humano
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
NO931224L (no) Fremgangsmaate for spalting av proteiner
PT772450E (pt) Metodos para tratar disturbios hemorragicos
ATE270327T1 (de) Verfahren zur präparation von humanem aktiviertem protein c
NO931773D0 (no) Fremgangsmaate ved fremstilling av fibrinogen
ATE45968T1 (de) Verfahrung zur herstellung von ungesaettigen polyestern.
ATE151295T1 (de) Zweikomponenten-fibrinkleber zur verbesserung von in-vitro befruchtung
DE69637278D1 (de) Methode zur herstellung von thrombin
EA200200321A1 (ru) Апоптин-ассоциированный белок
FI953849A (fi) Menetelmä vampyyrilepakon syljen plasminogeeniaktivaattoreiden valmistamiseksi
DE3464599D1 (de) Alpha-allenic-alpha-amino acids
FI935707A (fi) Anvaendning av hirudinderivat som trombininhibitorer
NO20006671L (no) Fibrinforseglingsmiddel fra levringsfaktorer i fiskeblod

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96